The Use of Apatinib in Treating Nonsmall-Cell Lung Cancer: Case Report and Review of Literature

Apatinib is a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor receptor-2, which has been proved to be effective and safe in treating heavily pretreated patients with gastric cancer.

Bibliographic Details
Main Authors: Ding, Lin, Li, Qing-Jian, You, Kai-Yun, Jiang, Zhi-Min, Yao, He-Rui
Format: Online
Language:English
Published: Wolters Kluwer Health 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902403/
id pubmed-4902403
recordtype oai_dc
spelling pubmed-49024032016-06-23 The Use of Apatinib in Treating Nonsmall-Cell Lung Cancer: Case Report and Review of Literature Ding, Lin Li, Qing-Jian You, Kai-Yun Jiang, Zhi-Min Yao, He-Rui 5700 Apatinib is a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor receptor-2, which has been proved to be effective and safe in treating heavily pretreated patients with gastric cancer. Wolters Kluwer Health 2016-05-20 /pmc/articles/PMC4902403/ /pubmed/27196461 http://dx.doi.org/10.1097/MD.0000000000003598 Text en Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Ding, Lin
Li, Qing-Jian
You, Kai-Yun
Jiang, Zhi-Min
Yao, He-Rui
spellingShingle Ding, Lin
Li, Qing-Jian
You, Kai-Yun
Jiang, Zhi-Min
Yao, He-Rui
The Use of Apatinib in Treating Nonsmall-Cell Lung Cancer: Case Report and Review of Literature
author_facet Ding, Lin
Li, Qing-Jian
You, Kai-Yun
Jiang, Zhi-Min
Yao, He-Rui
author_sort Ding, Lin
title The Use of Apatinib in Treating Nonsmall-Cell Lung Cancer: Case Report and Review of Literature
title_short The Use of Apatinib in Treating Nonsmall-Cell Lung Cancer: Case Report and Review of Literature
title_full The Use of Apatinib in Treating Nonsmall-Cell Lung Cancer: Case Report and Review of Literature
title_fullStr The Use of Apatinib in Treating Nonsmall-Cell Lung Cancer: Case Report and Review of Literature
title_full_unstemmed The Use of Apatinib in Treating Nonsmall-Cell Lung Cancer: Case Report and Review of Literature
title_sort use of apatinib in treating nonsmall-cell lung cancer: case report and review of literature
description Apatinib is a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor receptor-2, which has been proved to be effective and safe in treating heavily pretreated patients with gastric cancer.
publisher Wolters Kluwer Health
publishDate 2016
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902403/
_version_ 1613592977249140736